Advertisement

Chemische Noxen und Pharmaka

  • Winfried Mohr
Chapter

Zusammenfassung

Oral aufgenommenes kolloidales Aluminiumhydroxyd zur Verringerung der Hyperphosphatämie durch enterale Bildung unlöslicher Aluminiumphosphate [80] führt bei Dialysepatienten zur Vermehrung des Körperaluminiumgehalts [83].

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Alloway JA, Salata MP (1995) Quinidine-induced rheumatic syndromes. Semin Arthritis Rheum 24:315–322PubMedCrossRefGoogle Scholar
  2. 2.
    Axhausen G (1919) Die umschriebenen Knorpel-Knochenläsionen des Kniegelenks. Berl Klin Wochenschr 56:265–269Google Scholar
  3. 3.
    Bailey RR, Kirk JA, Peddie BA (1983) Norfloxacin-induced rheumatic disease. N Z Med J 96:590PubMedGoogle Scholar
  4. 4.
    Bartz-Bazzanella P, Genth E, Pollmann HJ, Schröder JM, Völker A (1992) Eosinophilie-Myalgie-Syndrom mit Fasziitis und interstitieller Myositis nach L-Tryptophan Einnahme. Z Rheumatol 51:3–13PubMedGoogle Scholar
  5. 5.
    Basilevskaja ZV (1979) Pathogenese orthopädischer Deformitäten bei der Kaschin-Beckschen Krankheit (Osteoarthrosis deformans endemica). Beitr Orthop Traumatol 26:427–433PubMedGoogle Scholar
  6. 6.
    Beck (1906) Zur Frage der Osteoarthritis deformans endemica im Transbaikalgebiet (russ.). Zitiert nach Schipatschoff [108]Google Scholar
  7. 7.
    Bellamy R, Wood TP (1978) Graphite localization in the synovial membrane of the knee. J Bone Joint Surg [Am] 60:1149–1151Google Scholar
  8. 8.
    Bentley G (1971) Papain-induced degenerative arthritis of the hip in rabbits. J Bone Joint Surg [Br] 53:324–337Google Scholar
  9. 8a.
    Bernard-Beaubois K, Hecquet C, Hayem G, Rat P, Adolphe M (1998) In vitro study of cytotoxicity of quinolones on rabbit tenocytes. Cell Biol Toxicol 14:283–292PubMedCrossRefGoogle Scholar
  10. 9.
    Berntsen E (1967) Epiphyseal growth zones in acute lathyrism. Acta Pathol Microbiol Scand 69:161–178CrossRefGoogle Scholar
  11. 10.
    Berstad A, Olafsson S, Tefera S, Berstad K, Hundal Ø, Bergseth M, Wilhelmsen I (1996) Bismuth therapy for Helicobacter pylori infection. A review of five years experience at a university hospital in Norway. J Physiol Pharmacol 47:31–49PubMedGoogle Scholar
  12. 11.
    Beutler M, Hartmann K, Kuhn M, Gartmann J (1994) Arthralgias and omeprazole. Br Med J 309:1620Google Scholar
  13. 12.
    Bolanos AA, Demizio JP, Vigorita VJ, Bryk E (1996) Lead poisoning from an intra-articular shotgun pellet in the knee treated with arthroscopic extraction and chelation therapy. A case report. J Bone Joint Surg [Am] 78:422–426Google Scholar
  14. 13.
    Bouissou H, Caujolle D, Caujolle F, Milhaud G (1978) Toxicologie expérimentale.-Tissus cartilagineux et acide nalidixique. C R Acad Sci Paris 286:1743–1746Google Scholar
  15. 14.
    Brown WR (1996) Comparative histopathologic evaluation of animal studies: Murine studies with L-tryptophan and constituents. J Rheumatol (Suppl 46) 23:99–110Google Scholar
  16. 15.
    Buge A, Hubault A, Rancurel G (1975) Les arthropathies de l’intoxication par le bismuth. Rev Rhum 42:721–729PubMedGoogle Scholar
  17. 16.
    Cantani A (1873) Latirismo (Lathyrismus). Lezione clinica illustrata da tre casi clinici. Morgagni, Milano 15:745–765Google Scholar
  18. 17.
    Chung A, Older SA (1997) Interferon-a associated arthritis. J Rheumatol 24:1844–1845PubMedGoogle Scholar
  19. 18.
    Cohrs P (1941) Zur pathologischen Anatomie und Pathogenese der chronischen Fluorvergiftung des Rindes. Dtsch Tierärztl Wochenschr 49:352–357Google Scholar
  20. 19.
    Culpepper RC, Williams RG, Mease PJ, Koepsell TD, Kobayashi JM (1991) Natural history of the eosinophiliamyalgia syndrome. Ann Intern Med 115:437–442PubMedGoogle Scholar
  21. 20.
    Dagan R, Schlaeffer F, Einhorn M (1990) Parenteral fluoroquinolones in children with life-threatening infections. Infection 18:237–238PubMedCrossRefGoogle Scholar
  22. 21.
    Der Stern (1997) „Die Schatten des Gaskriegs“. Der Stern, 50. Jahrg, Heft 47, S 52–56Google Scholar
  23. 22.
    Dingle JT, Lucy JA, Fell HB (1961) Studies on the mode of action of excess of vitamin A. 1. Effect of excess of vitamin A on the metabolism and composition of embryonic chick-limb cartilage grown in organ culture. Biochem J 79:497–500PubMedGoogle Scholar
  24. 23.
    Donck JB, Segaert MF, Vanrenterghem YF (1994) Fluoroquinolones and Achilles tendinopathy in renal transplant recipients. Transplantation 58:736–737PubMedGoogle Scholar
  25. 24.
    Du Toit GT (1979) Hip disease of Mseleni. Clin Orthop 141:223–236PubMedGoogle Scholar
  26. 25.
    Eamens GJ, Macadam JF, Laing EA (1984) Skeletal abnormalities in young horses associated with zinc toxicity and hypocuprosis. Aust Vet J 61:205–207PubMedCrossRefGoogle Scholar
  27. 26.
    Ebisuno S, Inagaki T, Kohjimoto Y, Ohkawa T (1997) The cytotoxic effects of fleroxacin and ciproflaxacin on transitional cell carcinoma in vitro. Cancer 80:2263–2267PubMedCrossRefGoogle Scholar
  28. 27.
    Editorial (1985) Mseleni joint disease. Lancet 2:483–484Google Scholar
  29. 28.
    Eisen D, Hakim MD (1998) Minocycline-induced pigmentation. Incidence, prevention and management. Drug Safety 18:431–440PubMedCrossRefGoogle Scholar
  30. 29.
    Ellis (1875) A case of probable Lead-poisening, resulting fatally from a Bullett lodged in the knee-joint Twelfe Years previously. Boston Med Surg J 91:472–473Google Scholar
  31. 30.
    Eloesser L (1918) Wounds of the joints. Boston Med Surg J 178:555–567Google Scholar
  32. 31.
    Escalante A, Fischbach M (1998) Musculoskeletal manifestations, pain, and quality of life in Persian Gulf War veterans referred for rheumatologic evaluation. J Rheumatol 25:2228–2235PubMedGoogle Scholar
  33. 32.
    Fasske E (1963) Enzymhistochemische Untersuchungen beim experimentellen Neurolathyrismus. Frankfurt Z Pathol 72:419–427Google Scholar
  34. 33.
    Fellingham SA, Elphinstone CD, Wittmann W (1973) Mseleni joint disease: Background and prevalence. S Afr Med J 47:2173–2180PubMedGoogle Scholar
  35. 34.
    Ferrari AJL, Rothfuss S, Schumacher HR (1997) Dialysis arthropathy: Identification and evaluation of a subset of patients with unexplained inflammatory effusions. J Rheumatol 24:1780–1786PubMedGoogle Scholar
  36. 35.
    Fincham JE, Hough FS, Taljaard JJF, Capatos D (1985) Mseleni joint disease. Part I. An animal model? S Afr J Med 67:51–57Google Scholar
  37. 36.
    Fischbach M, Escalante A (1995) Musculoskeletal manifestations, pain and quality of live in Gulf War veterans. Arthritis Rheum (Suppl) 38:S323 (Abstr 1021)Google Scholar
  38. 37.
    Förster C, Kociok K, Shakibaei M, Merker H-J, Stahlmann R (1996) Quinolone-induced cartilage lesions are not reversible in rats. Arch Toxicol 70:474–481PubMedCrossRefGoogle Scholar
  39. 38.
    Gardner DL (1992) Pathological basis of the connective tissue diseases. Edward Arnold, London Melbourne AucklandGoogle Scholar
  40. 39.
    Garzón FJO, Mendoza ACZ, Ruiz AA, Vallinas JMS, Villanueva MG, Ripoll AR, Gutiérrez JB (1982) Intoxicacion epidémica por aceite adulterado: una nueva forma de sindrome esclerodermiforme. Med Clin (Barcelona) 79:1–8Google Scholar
  41. 40.
    Garzon FJO, Santana CL, Ruiz AA, Meana CR (1983) The toxic-oil syndrome: A new cause of the carpal-tunnel syndrome. N Engl J Med 309:1455Google Scholar
  42. 41.
    Ge K, Xue A, Bai J, Wang S (1983) Keshan disease—an endemic cardiomyopathy in China. Virchows Arch Pathol Anat 401:1–15CrossRefGoogle Scholar
  43. 42.
    Gerber LH, Helfgott RK, Gross EG, Hicks JE, Ellenberg SS, Peck GL (1984) Vertebral abnormalities associated with synthetic retinoid use. J Am Acad Dermatol 10:817–823PubMedCrossRefGoogle Scholar
  44. 43.
    Gillet P, Blum A, Hestin D et al. (1995) Magnetic resonance imaging may be an asset to diagnose and classify fluoroquinolone-associated Achilles tendinitis. Fundam Clin Pharmacol 9:52–56PubMedCrossRefGoogle Scholar
  45. 44.
    Gough A, Barsoum NJ, Mitchell L, McGuire EJ, de la Iglesia FA (1979) Juvenile canine drug-induced arthropathy: Clinicopathological studies on articular lesions caused by oxolinic and pipemidic acids. Toxicol Appl Pharmacol 51:177–187PubMedCrossRefGoogle Scholar
  46. 45.
    Gough A, Johnson R, Campbell E et al. (1996) Quinolone arthropathy in immature rabbits treated with the fluoroquinolone, PD 117596. Exp Toxic Pathol 48:225–232Google Scholar
  47. 46.
    Grady EP, Carpenter MT, Battafarano DF, Older SA, Koenig CD (1995) Rheumatologic findings in Persian Gulf War veterans. Arthritis Rheum. (Suppl) 38:S323 (Abstr 1020)Google Scholar
  48. 47.
    Grimmett RER, Mcintosh IG, Wall EM, Hopkirk CSM (1937) Chronic zinc-poisoning of pigs. J Agricult 4:216–223Google Scholar
  49. 48.
    Guingamp C, Gegout-Pottie P, Philippe L, Terlain B, Netter P, Gillet P (1997) Mono-iodoacetate-induced experimental osteoarthritis. A dose-response study of loss of mobility, morphology, and biochemistry. Arthritis Rheum 40:1670–1679PubMedCrossRefGoogle Scholar
  50. 49.
    Gunson DE, Kowalczyk DF, Shoop CR, Ramberg CF (1982) Environmental zinc and cadmium pollution associated with generalized osteochondrosis, osteoporosis, and nephrocalcinosis in horses. J Am Vet Med Assoc 180:295–299PubMedGoogle Scholar
  51. 50.
    Hernandez-Bronchud MP (1982) Crippling deformities in Spanish toxic epidemic syndrome. Lancet 2:829PubMedCrossRefGoogle Scholar
  52. 51.
    Hertzman PA (1996) Criteria for the definition of the eosinophilia-myalgia syndrome. J Rheumatol (Suppl 46) 23:7–12Google Scholar
  53. 52.
    Hildebrand H, Kempka G, Schlüter G, Schmidt M (1993) Chondrotoxicity of quinolones in vivo and in vitro. Arch Toxicol 67:411–415PubMedCrossRefGoogle Scholar
  54. 53.
    Ingham B, Brentnall DW, Dale EA, McFadzean JA (1977) Arthropathy induced by antibacterial fused N-Alkyl-4-pyridone-3-carboxylic acids. Toxicol Letters 1:21–26CrossRefGoogle Scholar
  55. 54.
    Jorgensen C, Anaya JM, Didry C et al. (1991) Arthropathies et tendinopathie Achilléenne induites par la péfloxacine. A propos d’une observation. Rev Rhum 58:623–625PubMedGoogle Scholar
  56. 55.
    Kalbhen DA (1982) Arthrosis deformans. Experimentell-parmakologische Studien und ihre klinische Bedeutung. Eular, Basel (Schweiz)Google Scholar
  57. 56.
    Kaschin (1861) Über die Verbreitung von Kropf und Kretinismus im Russischen Reiche (russ.). Zitiert nach Schipatschoff [108]Google Scholar
  58. 57.
    Kashida Y, Kato M (1997) Characterization of fluoroquinolone-induced Achilles tendon toxicity in rats: Comparison of toxicities of 10 fluoroquinolones and effects of anti-inflammatory compounds. Antimicrobial Agents Chemother 41:2389–2393Google Scholar
  59. 58.
    Kato M, Onodera T (1988) Morphological investigation of osteochondrosis induced by ofloxacin in rats. Fundamental Appl Toxicol 11:120–131CrossRefGoogle Scholar
  60. 59.
    Kato M, Takada S, Kashida Y, Nomura M (1995) Histological examination on Achilles tendon lesions induced by quinolone antibacterial agents in juvenile rats. Toxicol Pathol 23:385–392PubMedCrossRefGoogle Scholar
  61. 60.
    Key JA (1940) Foreign body arthritis. Surg Gynec Obstet 70:897–902Google Scholar
  62. 61.
    Kiburz D (1984) Intra-articular drug abuse. J Bone Joint Surg [Am] 66:1469Google Scholar
  63. 62.
    Kilbourne EM, Bernert JT, Posada de la Paz M et al. (1988) Chemical correlates of pathogenicity of oils related to the toxic oil syndrome epidemic in Spain. Am J Epidemiol 127:1210–1227PubMedGoogle Scholar
  64. 63.
    Kilcoyne RF, Cope R, Cunningham W, Nardella FA, Denman S, Franz TJ, Hanifin J (1986) Minimal spinal hyperostosis with low-dose isotretinoin therapy. Invest Radiol 21:41–44PubMedCrossRefGoogle Scholar
  65. 64.
    Knitzer RH, Needleman BW (1991) Musculoskeletal syndromes associated with acne. Semin Arthritis Rheum 20:247–255PubMedCrossRefGoogle Scholar
  66. 65.
    Kopp S, Mejersjö C, Clemensson E (1983) Induction of osteoarthrosis in the Guinea pig knee by papain. Oral Pathol 55:259–266CrossRefGoogle Scholar
  67. 65a.
    Kötter I, Müller CA, Einsele H, Mohren M, Kanz L (1999) Interferon-α-assoziierte Polyarthritis. Mögliche Induktion einer seropositiven rheumatoiden Arthritis durch Interferon-α: zwei Fallbeispiele und Literaturübersicht. Z Rheumatol 58:185–195PubMedCrossRefGoogle Scholar
  68. 66.
    Kowalczyk DF, Gunson DE, Shoop CR, Ramberg CF (1986) The effects of natural exposure to high levels of zinc and cadmium in the immature pony as a function of age. Environ Res 40:285–300PubMedCrossRefGoogle Scholar
  69. 67.
    Leichsenring J, Sell S (1994) Kokaininduzierte multiple Osteonekrosen. Aktuel Rheumatol 19:33–35CrossRefGoogle Scholar
  70. 68.
    Leonard MH (1969) The solution of lead by synovial fluid. Clin Orthop 64:255–261PubMedGoogle Scholar
  71. 69.
    Lewin L (1911) Das toxische Verhalten von metallischem Blei und besonders von Bleigeschossen im thierischen Körper. Arch Klin Chir 94:937–972Google Scholar
  72. 70.
    Lockitch G, Fellingham SA, Wittmann W, De Villiers PD, De Wet IS, Du Toit GT (1973) Mseleni joint disease: The pilot clinical survey. S Afr Med J 47:2283–2293PubMedGoogle Scholar
  73. 71.
    Lockitch G, Fellingham SA, Elphinstone CD (1973) Mseleni joint disease: A radiological study of two affected families. S Afr Med J 47:2366–2376PubMedGoogle Scholar
  74. 72.
    Martel-Pelletier J, Pelletier J-P (1986) Degradative changes in human articular cartilage induced by chemotherapeutic agents. J Rheumatol 13:164–174PubMedGoogle Scholar
  75. 73.
    Martinez-Tello FJ, Navas-Palacios JJ, Ricoy JR et al. (1982) Pathology of a new toxic syndrome caused by ingestion of adulterated oil in Spain. Virchows Arch Pathol Anat 397:261–285PubMedGoogle Scholar
  76. 74.
    Mateo IM, Izquierdo M, Fernandez-Dapica MP, Navas J, Cabello A, Gomez-Reino JJ (1984) Toxic epidemic syndrome: musculoskeletal manifestations. J Rheumatol 11:333–338PubMedGoogle Scholar
  77. 75.
    Matteson EL, Johnson BW, Maher JD (1998) Arthralgias, myalgias, and autoimmune hepatitis with minocycline therapy. J Rheumatol 25:1653–1654PubMedGoogle Scholar
  78. 76.
    Mayeno AN, Lin F, Foote CS, Loegering DA, Ames MM, Hedberg CW, Gleich GJ (1990) Characterization of “peak E,“ a novel amino acid associated with eosinophilia-myalgia syndrome. Science 250:1707–1708PubMedCrossRefGoogle Scholar
  79. 77.
    Meier CR, Jick H (1997) Omeprazole, H2 blockers, and polyarthralgia: case-control study. Br Med J 315:1283Google Scholar
  80. 78.
    Mont MA, Mathur SK, Frondoza CG, Hungerford DS (1996) The effects of ciprofloxacin on human chondrocytes in cell culture. Infection 24:151–155PubMedCrossRefGoogle Scholar
  81. 79.
    Morrow JD, Schroeder HA, Pery HM (1953) Studies on the control of hypertension by hyphex. II. Toxic reactions and side effects. Circulation 8:829–839PubMedGoogle Scholar
  82. 80.
    Mutschier E (1991) Arzneimittelwirkungen. Lehrbuch der Pharmakologie und Toxikologie. 6. Auflage. Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, S 599–602Google Scholar
  83. 81.
    Neidel J, Sova L, Schroers B, Sintermann F, Manzke O, Bohlen H (1998) Effects of methotrexate on normal articular cartilage in vitro and in vivo. Ann Rheum Dis 57:414–421PubMedCrossRefGoogle Scholar
  84. 82.
    Netter P, Kessler M, Burnel D, Hutin M-F, Delones S, Benoit J, Gaucher A (1984) Aluminium in the joint tissues of chronic renal failure patients treated with regular hemodialysis and aluminium compounds. J Rheumatol 11:66–70PubMedGoogle Scholar
  85. 83.
    Netter P, Kessler M, Gaucher A, Bannwarth B (1990) Does aluminium have a pathogenic role in dialysis associated arthropathy? Ann Rheum Dis 49:573–575PubMedCrossRefGoogle Scholar
  86. 84.
    Nicoll EDV, Foster EA (1960) Granulomatous tenosynovitis due to beryllium. Histological and spectrographic analysis. A case report. J Bone Joint Surg [Am] 42:1087–1090Google Scholar
  87. 85.
    Nurse GT (1985) Slow virus in Mseleni joint disease? Lancet 2:784PubMedCrossRefGoogle Scholar
  88. 86.
    Oreizi-Esfahani M, Mikdashi J, McPhillips J, Hochberg MC (1995) Musculoskeletal and rheumatic symptoms among Persian Gulf war veterans. Arthritis Rheum (Suppl) 38:S323 (Abstr 1022)Google Scholar
  89. 87.
    Parker J, Scheck M (1981) Thallium chondrodystrophy in chick embryos: Ultrastructural changes in the epiphyseal plate. Calcif Tissue Int 33:57–69PubMedCrossRefGoogle Scholar
  90. 88.
    Peh WCG, Reinus WR (1995) Lead arthropathy: a cause of delayed onset lead poisoning. Skeletal Radiol 24:357–360PubMedGoogle Scholar
  91. 89.
    Perrot S, Ziza JM, de Bourran-Cauet G, Desplaces N, Lachand AT (1991) Nouvelle complication liée aux quinolones: la rupture du tendon d’Achille. Presse Méd 20:1234PubMedGoogle Scholar
  92. 90.
    Perry HM, Schroeder HA (1954) Syndrome simulating collagen disease caused by hydralazine (apresoline). JAMA 154:670–673Google Scholar
  93. 91.
    Pertuiset E, Lenoir G, Jehanne M, Douchain F, Guillot M, Menkes CJ (1989) Tolérance articulaire de la péfloxacine et de l’ofloxacine chez les enfants et adolescents atteints de mucoviscidose. Rev Rhum 56:735–740PubMedGoogle Scholar
  94. 92.
    Pierfitte C, Royer RJ (1996) Tendon disorders with fluoroquinolones. Thérapie 51:419–420PubMedGoogle Scholar
  95. 93.
    Pigeon G, Genest J (1960) Prolonged hydralazine hydrochloride administration in 132 hypertensive patients—study of toxicity. Can Med Ass J 83:743–746PubMedGoogle Scholar
  96. 94.
    Pittsley RA, Yoder FW (1983) Retinoid hyperostosis. Skeletal toxicity associated with long-term administration of 13-cis-retinoic acid for refractory ichthyosis. N Engl J Med 308:1012–1014PubMedCrossRefGoogle Scholar
  97. 95.
    Ponseti IV, Baird WA (1952) Scoliosis and dissecting aneurysm of the aorta in rats fed with lathyrus odoratus seeds. Am J Pathol 27:1059–1064Google Scholar
  98. 96.
    Ponseti IV, Shepard RS (1954) Lesions of mesodermal tissues in rats fed Lathyrus odoratus seeds. Fed Proc 13:473 (Abstr)Google Scholar
  99. 97.
    Ponseti IV, Shepard RS (1954) Lesions of the skeleton and of other mesodermal tissues in rats fed sweet-pea (lathyrus odoratus) seeds. J Bone Joint Surg [Am] 36:1031–1058Google Scholar
  100. 98.
    Primm DD (1984) Lead arthropathy-progressive destruction of a joint by a retained bullet. Case report. J Bone Joint Surg [Am] 66:292–294Google Scholar
  101. 99.
    Raab P, Krauspe R, Kühl J (1997) Multifocal osteonecrosis in children and adolescents following polychemotherapy. J Bone Joint Surg Suppl II [Br] 79:S184 (Abstr 0 176)Google Scholar
  102. 100.
    Ribard P, Audisio F, Kahn M-F et al. (1992) Seven Achilles tendinitis including 3 complicated by rupture during fluoroquinolone therapy. J Rheumatol 19:1479–1481PubMedGoogle Scholar
  103. 101.
    Roberts RD, Wong SW, Theil GB (1983) An unusual case of lead arthropathy. Arthritis Rheum 26:1048–1051PubMedCrossRefGoogle Scholar
  104. 102.
    Rodriguez M, Noguera E, Villar RS del, Vegazo S, Mulero J, Cruz J, Larrea A (1982) Toxic synovitis from denatured rapeseed oil. Arthritis Rheum 25:1477–1480PubMedCrossRefGoogle Scholar
  105. 103.
    Royer RJ, Delongeas JL, Netter P, Faure G, Mur JM, Burnel D, Gaucher A (1982) Inflammatory effect of aluminium phosphate on rat paws. Path Biol 30:211–215Google Scholar
  106. 104.
    Rumbak MJ, Pitcock JA, Palmieri GMA, Robertson JT (1991) Black bones following long-term minocycline treatment. Arch Pathol Lab Med 115:939–941PubMedGoogle Scholar
  107. 105.
    Sampson J, Graham R, Hester HR (1942) Studies on feeding zinc to pigs. Cornell Vet 32:225–236Google Scholar
  108. 106.
    Savola J (1983) Arthropathy induced by beta blockade. Br Med J 287:1256–1257CrossRefGoogle Scholar
  109. 107.
    Schaad UB, Wedgwood-Krucko J (1987) Nalidixic acid in children: Retrospective matched controlled study for cartilage toxicity. Infection 15:165–168PubMedCrossRefGoogle Scholar
  110. 108.
    Schipatschoff WG (1931) Die Kaschin-Becksche Krankheit (Osteoarthritis endemica). Dtsch Arch Klin Med 31:133–145Google Scholar
  111. 109.
    Schlesinger N, Baker DG, Schumacher HR (1997) Persian Gulf War myalgia syndrome. J Rheumatol 24:1018–1019PubMedGoogle Scholar
  112. 110.
    Schlüter G (1987) Ciprofloxacin: Review of potential toxicologic effects. Am J Med (Suppl 4 A) 82:91–93Google Scholar
  113. 111.
    Schnabel A, Arlt AC, Gross WL (1992) Behandlung des chronischen Eosinophilie-Myalgie-Syndroms—Wirksame Therapieregime werden erkennbar. Z Rheumatol 51:155–157PubMedGoogle Scholar
  114. 112.
    Schumacher HR (1998) Patients with „Gulf War Syndrome.“ Even without etiologic answers treatment studies are needed. J Rheumatol 25:2059–2061PubMedGoogle Scholar
  115. 113.
    Sclafani SJA, Vuletin JC, Twersky J (1985) Lead arthropathy: Arthritis caused by retained intra-articular bullets. Radiology 156:299–302PubMedGoogle Scholar
  116. 114.
    Selye H (1957) Lathyrism. Rev Can Biol 16:1–82PubMedGoogle Scholar
  117. 115.
    Silver RM (1996) Pathophysiology of the eosinophiliamyalgia syndrome. J Rheumatol (Suppl 46) 23:26–36Google Scholar
  118. 116.
    Silver RM, Heyes MP, Maize JC, Quearry B, Vionnet-Fuasset M, Sternberg EM (1990) Scleroderma, fasciitis, and eosinophilia associated with the ingestion of tryptophan. N Engl J Med 322:874–881PubMedCrossRefGoogle Scholar
  119. 117.
    Simon J, Guyot A (1990) Pefloxacin: safety in man. J Antimicrob Chemother (Suppl B) 26:215–218PubMedGoogle Scholar
  120. 118.
    Slavin RE, Swedo J, Cartwright J, Viegas S, Custer EM (1988) Lead arthritis and lead poisoning following bullet wounds: a clinicopathologic, ultrastructural and microanalytic study of two cases. Hum Pathol 19:223–235PubMedCrossRefGoogle Scholar
  121. 119.
    Slikkerveer A, de Wolff FA (1989) Pharamcokinetics and toxicity of bismuth compounds. Med Toxicol Adverse Drug Exp 4:303–323PubMedGoogle Scholar
  122. 120.
    Sokoloff L (1985) Endemic forms of osteoarthritis. Clin Rheum Dis 11:187–202PubMedGoogle Scholar
  123. 121.
    Sokoloff L (1989) The history of Kashin-Beck disease. NY State J Med 89:343–351Google Scholar
  124. 122.
    Sokoloff L (1990) Acquired chondronecrosis. Ann Rheum Dis 49:262–264PubMedCrossRefGoogle Scholar
  125. 123.
    Stemmer KL (1976) Pharmacology and toxicology of heavy metals: Bismuth. Pharmac Ther A 1:153–155Google Scholar
  126. 124.
    Stockman R (1929) Lathyrism. J Pharmacol Exp Rev 37:43–53Google Scholar
  127. 125.
    Switz DM, Elmorshidy ME, Deyerle WM (1976) Bullets, joints, and lead intoxication. A remarkable and instructive case. Arch Intern Med 136:939–941PubMedCrossRefGoogle Scholar
  128. 126.
    Swygert LA, Maes EF, Sewell LE, Miller L, Falk H, Kilbourne EM (1990) Eosinophilia-myalgia syndrome. Results of national surveillance. JAMA 264:1698–1703PubMedCrossRefGoogle Scholar
  129. 127.
    Tabuenca JM (1981) Toxic-allergic syndrome caused by ingestion of rapeseed oil denatured with aniline. Lancet 2:567–568PubMedCrossRefGoogle Scholar
  130. 127a.
    Takase T, Imai S, Maeda T, Inoue K, Hukuda S (1999) Influence of retinyl acetate on osteochondral junction chrondrozytes in C3H and balb mice. J Rheumatol 26:156–165PubMedGoogle Scholar
  131. 128.
    Tatsumi H, Senda H, Yatera S, Takemoto Y, Yamayoshi M, Ohnishi K (1978) Toxicological studies on pipemidic acid. V. Effect on diarthrodial joints of experimental animals. J Toxicol Sci 3:357–367PubMedCrossRefGoogle Scholar
  132. 129.
    Taurog A, Dorris ML, Doerge DR (1996) Minocycline and the thyroid: Antithyroid effects of the drug, and the role of thyroid peroxidase in minocycline-induced black pigmentation of the gland. Thyroid 6:211–219PubMedGoogle Scholar
  133. 130.
    Thomas L (1956) Reversible collapse of rabbit ears after intravenous papain, and prevention of recovery by cortisone. J Exp Med 104:245–252PubMedCrossRefGoogle Scholar
  134. 131.
    Toxic epidemic syndrome study group (1982) Toxic epidemic syndrome, Spain, 1981. Lancet 2:697–702CrossRefGoogle Scholar
  135. 132.
    Turk B, Turk V, Turk D (1997) Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors. Biol Chem 378:141–150PubMedGoogle Scholar
  136. 133.
    Varga J, Uitto J, Jimenez SA (1992) The cause and pathogenesis of the eosinophilia-myalgia syndrome. Ann Int Med 116:140–147PubMedGoogle Scholar
  137. 134.
    Waller PC, Ramsay LE (1985) Do ß blockers cause arthropathy?. A case control study. Br Med J 291:1684CrossRefGoogle Scholar
  138. 135.
    Warren RW (1997) Rheumatologic aspects of pediatric cystic fibrosis patients treated with fluoroquinolones. Pediatr Infect Dis J 16:118–122PubMedCrossRefGoogle Scholar
  139. 136.
    Wawzonek S, Ponseti IV, Shepard RS, Wiedenmann LG (1955) Epiphyseal plate lesions, degenerative arthritis, and dissecting aneurysm of the aorta produced by aminonitriles. Science 121:63–65PubMedCrossRefGoogle Scholar
  140. 137.
    Westbury LW, Najera A (1997) Minocycline-induced intraoral pharmacogenic pigmentation: Case reports and review of the literature. J Periodontol 68:84–91PubMedGoogle Scholar
  141. 138.
    Willoughby RA, Oyaert W (1973) Zinkvergiftiging bij veulens. Vlaams Diergeneeskundig Tijdschrift 42:134–143Google Scholar
  142. 139.
    Willoughby RA, MacDonald E, McSherry BJ, Brown G (1972) Lead and zinc poisoning and the interaction between Pb and Zn poisoning in the foal. Can J Comp Med 36:348–359PubMedGoogle Scholar
  143. 140.
    Windier EC, Smith RB, Bryan WJ, Woods GW (1978) Lead intoxication and traumatic arthritis of the hip secondary to retained bullet fragments. J Bone Joint Surg [Am] 60:254–255Google Scholar
  144. 141.
    Wittman W, Fellingham SA (1970) Unusual hip disease in remote part of Zululand. Lancet 1:842–843CrossRefGoogle Scholar
  145. 142.
    Wyeth JW, Pounder RE, Duggan AE et al. (1996) The safety and efficacy of ranitidine bismuth citrate in combination with antibiotics for the eradication of Helicobacter pylori. Aliment Pharmacol Ther 10:623–630PubMedCrossRefGoogle Scholar
  146. 143.
    Yabe K, Yoshida K, Yamamoto N et al. (1997) Diagnosis of quinolone-induced arthropathy in juvenile dogs by use of magnetic resonance (MR) imaging. J Vet Med Sci 59:597–599PubMedCrossRefGoogle Scholar
  147. 144.
    Yach D, Botha JL (1985) Mseleni joint disease in 1981: Decreased prevalence rates, wider geographical location than before, and socioeconomic impact of an endemic osteoarthrosis in an underdeveloped community in South Africa. Int J Epidemiol 14:276–284PubMedCrossRefGoogle Scholar
  148. 145.
    Zabraniecki L, Negrier I, Vergne P, Arnaud M, Bonnet C, Bertin P, Treves R (1996) Fluoroquinolone induced tendinopathy: Report of 6 cases. J Rheumatol 23:516–520PubMedGoogle Scholar
  149. 146.
    Zhang G, Liu J (1989) An experimental animal model of Kashin-Beck disease. Ann Rheum Dis 48:149–152PubMedCrossRefGoogle Scholar
  150. 147.
    Zoma A, Pullar T, Capell H (1984) Arthropathy induced by beta blockade. Br Med J 288:237–238CrossRefGoogle Scholar
  151. 148.
    Zweymüller K, Plenk H (1968) Reißfestigkeitsuntersuchungen an Sehnen-Knochenverbindungen bei lathyritischen Ratten. Med Exp 18:65–74PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2000

Authors and Affiliations

  • Winfried Mohr
    • 1
  1. 1.Universität Ulm Abt. PathologieUlmGermany

Personalised recommendations